semaglutide and breast cancer GLP-1 medications may offer benefits beyond weight loss diabetes management, including improved outcomes for patients who are obese or have type 2 diabetes, according to new research. The study Unconventional Applications of Semaglutide and

In the STEP and SURMOUNT trial programs, participants treated with semaglutide and tirzepatide respectively achieved average weight reductions of 15 to 22% of total body weight, losses that had previously been achievable only through bariatric surgery [8,9]

The transcription factor FOXA1 is among the most effective activators of human FABP1 70

Researchers interested in broader pain management approaches can explore peptides for pain relief and options for specific conditions like fibromyalgia , which shares symptom overlap with lupus

The microdosing tirzepatide chart covers sub-standard dosing approaches in detail

Beyond the Scale Scale weight captures only part of the picture

Adapting to a healthier diet and workout routine, as well as finding the right medication and diet, takes time and experimentation